Meta-analysis of Relacorilant Plus Nab-paclitaxel Efficacy in Patients With Platinum-resistant Ovarian Cancer (PROC) Enrolled to ROSELLA and Study 552

Presented: European Society for Medical Oncology, 26 October 2026, Madrid, Spain

Presenter: Alexander B. Olawaiye, M.D.


Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.

Download Poster

© 2026 Corcept Therapeutics, Incorporated

Privacy Notice | Terms of Use | Site Map | Your Privacy Choices | LinkedIn | Youtube

Privacy Notice

Terms of Use

Site Map

Your Privacy Choices

LinkedIn

Youtube